AiCuris

Showing 4 posts of 4 posts found.

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …

New chief executive for AiCuris

January 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, Holger Zimmermann, Rübsamen-Schaeff

Founded in 2006 as a spin-off from Bayer, AiCuris has found a new chief executive as Helga Rübsamen-Schaeff steps aside …

Merck image

Merck enters €110m virus alliance

October 16, 2012
Research and Development, Sales and Marketing AiCuris, Gilead, HCMV, Merck

Merck has gained access to AiCuris’ portfolio of investigational medicines targeting human cytomegalovirus (HCMV) via a global licensing agreement. It …

Dr Marie-Paule Richard joins AiCuris as CMO

January 26, 2011
Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development

German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …

Latest content